Insider Transactions in Q4 2022 at Logic Bio Therapeutics, Inc. (LOGC)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 16
2022
|
Daniel Gruskin Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,331
-100.0%
|
-
|
|
Nov 16
2022
|
Leon Chen Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
22,333
-100.0%
|
-
|
|
Nov 16
2022
|
Richard A Moscicki Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,916
-100.0%
|
-
|
|
Nov 16
2022
|
Frederic Chereau President, CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
253,811
-100.0%
|
-
|
|
Nov 16
2022
|
Michael S Wyzga Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,141
-100.0%
|
-
|
|
Nov 16
2022
|
Mark J Enyedy Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,921
-100.0%
|
-
|
|
Nov 16
2022
|
Mark A Kay Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
784,557
-100.0%
|
-
|